This explanation could be valid for the three tumors with BRCA1 promoter methylation and the tumor with a somatic BRCA2 mutation with LOH, which were not identified as HRD by BRCA1/2-like classifier and both BRCA1/2-like classifier and CHORD, respectively. This evidence concerns the gene BRCA2 and neoplasm.